title: Omalizumab in severe asthma: Evaluation of the clinical impact after its withdrawal.
authors.affiliation: Centro Hospitalar Tondela Viseu, Viseu, Portugal. Electronic address: martadias.sousa@gmail.com.
authors.forename: M
authors.initials: M
authors.lastname: D de Sousa
authors.affiliation: Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
authors.forename: C
authors.initials: C
authors.lastname: Ferreira
authors.affiliation: Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
authors.forename: A
authors.initials: A
authors.lastname: Arrobas
mesh_terms: D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008875:Middle Aged; D000069444:Omalizumab / Q000627:therapeutic use*; D012720:Severity of Illness Index; D028761:Withholding Treatment
chemical_list: D018927:Anti-Asthmatic Agents; D000069444:Omalizumab